Resultados financieros de METLEN del primer semestre de 2026

METLEN reportó resultados récord en el 1S26: ingresos de €3.987M (+11% interanual) y EBITDA de €550M (vs. €445M). El beneficio neto tras minoritarios cayó a €3,13M desde €254M, mientras el flujo de caja operativo permitió reducir la deuda neta ajustada en €728M y bajar el apalancamiento neto de 3,1x a 1,7x. La empresa reafirmó su guía 2026 de EBITDA entre €1.000–€1.150M y mantiene objetivos a medio plazo (€1.920–€2.080M), además de avanzar en acuerdos de galio y despliegue de BESS (≈0,4 GW operativos en Grecia/Italia y 1,6 GW adicionales en el sur y sudeste de Europa).

Analysis

METLEN’s real equity story is balance-sheet optionality, not the headline earnings line. When a capital-intensive platform cuts leverage this quickly while still funding BESS and a first critical-mineral offtake, the market can begin to underwrite project finance at a lower WACC; that matters more over the next 12-18 months than any single half-year print.

The second-order winner is METLEN’s own multiple: the stock should migrate from a cyclical metals discount toward an infrastructure/critical-input premium if execution holds. The knock-on loser is smaller European storage developers and industrial peers that rely on external capital and lack an integrated cash engine; METLEN can bid more aggressively for pipeline, equipment, and long-dated customers without sacrificing equity returns. The gallium contract is more important as a financing signal than as near-term P&L, because one anchor customer can de-risk the entire production curve.

Near term, the main risk is that investors dismiss the release because the bottom line is noisy and the market wants cash, not narrative. Over 1-3 months, the key catalyst is whether management converts this into higher guidance or visible project milestones; over 6-18 months, the thesis breaks if adjusted leverage stalls above ~2x or project delays force another capital raise.

Key Decisions for Investors

• Long MYTHF on pullbacks over the next 3-6 months; the risk/reward improves if adjusted leverage continues toward ~1.5x and the market starts capitalizing the business like a self-funding infrastructure platform rather than a cyclical miner/utility.
• Do not chase an opening gap higher in MYTHF; prefer staggered entry over 2-5 trading sessions because the durable catalyst is follow-through in guidance and project milestones, not the print itself.
• Set a hard falsification alert on MYTHF: if the next update shows adjusted leverage back above ~2.0-2.2x, BESS/gallium delays, or capex slippage, exit the idea rather than averaging down.
• No direct trade in GOOGL or SPGI from this release; the unnamed US tech counterparty is too opaque, and the read-through to semis/ratings is not yet investable until the customer economics are disclosed.
• If METLEN raises 2026 EBITDA guidance or signs a second gallium offtake within 1-3 months, add to MYTHF as a momentum-plus-fundamentals long; that would be the point where the rerating case becomes self-reinforcing.